EuroCareFinderExplore healthcare across Europe
← Back to EuroCareFinder

Diagnostic Test

Kveim Test

Diagnostics

Overview

Intradermal injection of a heated (pasteurized) saline suspension of sarcoid tissue obtained from a sarcoid spleen or lymph node. In patients with active sarcoidosis a dusky red nodule develops slowly over the next few weeks at the injection site. Histologic examination, an essential part of the complete test, reveals sarcoid tissue.

This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.

Quick facts about Kveim Test

Topic type
Diagnostic Test
Category
Diagnostics
MeSH classification
E01.370.225.812.871.300.540|E05.200.812.871.300.540|E05.478.594.890.300.540

Questions to discuss about Kveim Test

  • What does this topic mean in my situation?
  • Which type of healthcare professional should I speak with?
  • Are tests, assessments or follow-up appointments needed?
  • What treatment options or next steps may be relevant?
  • Where can I find reliable information before making decisions?

Finding care related to Kveim Test

EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.

Explore clinics across Europe

Browse the wider EuroCareFinder healthcare network using the interactive map.

Clinics related to Kveim Test

No clinics are currently linked directly to Kveim Test on EuroCareFinder.

As more clinics add detailed services, related providers may appear here.

Related topics

Explore healthcare providers

Use EuroCareFinder to browse clinics by country, specialty and available services.

Source: Medical Subject Headings (MeSH), produced by the U.S. National Library of Medicine. EuroCareFinder is not endorsed by the National Library of Medicine. MeSH version: 2026.